Two ME/CFS, yes, ME/CFS low dose naltrexone papers appear, one fibromyalgia report attempts to turn dosing protocols on their head, one patient blows through normal dose levels with spectacular success, Jarred Younger hunts for a more powerful naltrexone, and then...
A recent Australian study suggested an already FDA approved drug can revive the not so killer natural killer cells found in ME/CFS in the lab. If that finding translates to humans we’ll have a breakthrough in the one verified immune hole in ME/CFS – one...
Dr. Chheda’s Road to ME/CFS I met Dr. Chheda of the Center for Complex Diseases at Ron Davis’s Working Group Meetings funded by the Open Medicine Foundation. She graciously agreed to talk more about how she approaches treating ME/CFS in her practice. I was...
I was a 29-year-old career woman who had been burning the candle at both ends for as long as I can remember. I had a high-powered job that required weekly travel, both nationally and internationally, consulting for executive management teams in Fortune 500 companies...
Younger is studying a potentially more effective and side-effect free form of low dose naltrexone called dextro naltrexone. His botanicals study containing 9 plant compounds including resveratrol and cucurmin has wrapped up as well.
“Finding an objective neurochemical change in the brains of people who are used to being told that their problems are imaginary is pretty important…” Marco Loggia Jarred Younger has believed for quite some time that the glial cells in fibromyalgia...
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.